Roger A Kroes

Author PubWeight™ 24.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Neurobiology of 50-kHz ultrasonic vocalizations in rats: electrode mapping, lesion, and pharmacology studies. Behav Brain Res 2007 1.91
2 GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects. Neuropsychopharmacology 2012 1.74
3 Ultrasonic vocalizations of rats (Rattus norvegicus) during mating, play, and aggression: Behavioral concomitants, relationship to reward, and self-administration of playback. J Comp Psychol 2008 1.68
4 GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists. Expert Opin Investig Drugs 2013 1.07
5 The effects of selective breeding for differential rates of 50-kHz ultrasonic vocalizations on emotional behavior in rats. Dev Psychobiol 2009 1.00
6 Increasing SK2 channel activity impairs associative learning. J Neurophysiol 2012 0.94
7 A novel NMDA receptor glycine-site partial agonist, GLYX-13, has therapeutic potential for the treatment of autism. Neurosci Biobehav Rev 2011 0.91
8 Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation. J Proteome Res 2010 0.90
9 Effects of intraaccumbens amphetamine on production of 50 kHz vocalizations in three lines of selectively bred Long-Evans rats. Behav Brain Res 2010 0.88
10 Diabetes changes expression of genes related to glutamate neurotransmission and transport in the Long-Evans rat retina. Mol Vis 2013 0.87
11 Distinct patterns of gene expression in the left and right hippocampal formation of developing rats. Hippocampus 2006 0.86
12 Integrated chromosome 19 transcriptomic and proteomic data sets derived from glioma cancer stem-cell lines. J Proteome Res 2013 0.86
13 Gene expression patterns in hypoxic and post-hypoxic adult rat retina with special reference to the NMDA receptor and its interactome. Mol Vis 2009 0.85
14 The glycobiology of brain tumors: disease relevance and therapeutic potential. Expert Rev Neurother 2009 0.84
15 Use of ENCODE resources to characterize novel proteoforms and missing proteins in the human proteome. J Proteome Res 2014 0.83
16 Regional brain cholecystokinin changes as a function of friendly and aggressive social interactions in rats. Brain Res 2004 0.83
17 Regional brain cholecystokinin changes as a function of rough-and-tumble play behavior in adolescent rats. Peptides 2005 0.83
18 Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, irinotecan. Glycoconj J 2009 0.82
19 Chromosome 19 annotations with disease speciation: a first report from the Global Research Consortium. J Proteome Res 2012 0.82
20 Motor and locomotor responses to systemic amphetamine in three lines of selectively bred Long-Evans rats. Pharmacol Biochem Behav 2011 0.82
21 Brain regional neuropeptide changes resulting from social defeat. Behav Neurosci 2007 0.80
22 Integrative biological analysis for neuropsychopharmacology. Neuropsychopharmacology 2013 0.79
23 Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases. Anticancer Res 2002 0.79
24 The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant. Curr Neuropharmacol 2017 0.78
25 Comparative approaches in evolutionary psychology: molecular neuroscience meets the mind. Neuro Endocrinol Lett 2002 0.77
26 Rough-and-tumble play induces resilience to stress in rats. Neuroreport 2017 0.75